News
May 11, 2026
Kaiseraugst (Switzerland), Maastricht (Netherlands), 11 May, 2026
dsm-firmenich, leading innovators in nutrition, health, and beauty, today announced the opening of NextGen Itatiba, a fully dedicated pet nutrition premix facility located in Itatiba, São Paulo, Brazil. Developed in collaboration with Globalfood, the facility is focused on the production of vitamin and mineral premixes for domestic cats and dogs, and will serve as dsm-firmenich’s primary manufacturing and supply hub for pet nutrition in South America.
The inauguration marks dsm-firmenich’s latest investment in its growing global network of dedicated pet food premix facilities, following the recent openings of its European and North American facilities in Haag, Austria, and Tonganoxie, KS, USA respectively. Now with three connected dedicated pet food production sites, dsm-firmenich is uniquely positioned to shape the future of pet nutrition and deliver exceptional service to its partners across Europe, North and South America.
Next generation premix excellence, built by and for the pet nutrition experts of South America
NextGen Itatiba is located approximately 100 kilometers from São Paulo city, benefiting from access to key infrastructure and distribution networks which enables improved response to pet food brands across South America. The facility is operated by Globalfood, a long-established partner of dsm-firmenich with over 30 years of food technology and ingredient expertise. Under the agreement, Globalfood will act as a dedicated toll manufacturer, while dsm-firmenich retains full responsibility for formulation, raw material sourcing, quality control and product release.
Victor Hasserodt, General Manager at Globalfood states, “We are immensely excited to expand our successful partnership with dsm-firmenich as it brings its world-class pet nutrition solutions closer to customers in Brazil, South America and beyond. As part of our certified food ingredients campus, NextGen Itatiba benefits from well-established sustainability infrastructure including solar energy generation, water reuse systems and reforestation initiatives. With the combination of dsm-firmenich’s category-leading innovation focus and our responsible manufacturing expertise, we expect NextGen Itatiba to deliver incredible successes for pet food brands across South America.”
Built to food-grade certification standards with no production for other animal species onsite, NextGen Itatiba is designed to ensure pet nutrition is never in competition for capacity with commercial feed. In terms of production capability, the facility is equipped to blend virtually any dry powder ingredient, allowing manufacturers to tailor recipes to individual brands, their target markets, and the specific nutritional requirements of the pets they serve.
Investing in better for the world's furry friends
NextGen Itatiba is the latest addition to dsm-firmenich's growing global network of dedicated pet nutrition facilities, each designed to deliver food-grade, species-specific premix production in their respective regions. Its opening ensures that South American pet food manufacturers can access the same level of dedicated expertise available to dsm-firmenich customers in Europe and North America.
“This new facility opening forms part of a coordinated, long-term strategic commitment to pet nutrition as a priority growth category, backed by world-class formulation science and a global innovation pipeline,” comments Francisco Fienga, President, Brazil at dsm-firmenich.
“South America represents one of the fastest-growing markets for pet nutrition on the world stage. By establishing a dedicated facility at the heart of this high-growth market, dsm-firmenich is reinforcing its long-term commitment to this continent, and to the manufacturers, pet owners and - most importantly – the beloved pets that call it home”, adds Jose Fernandes, Vice President Regional Sales, Pet food, LAM at dsm-firmenich.
To learn more about dsm-firmenich’s capabilities and solutions for pet food, visit: https://www.dsm-firmenich.com/en/businesses/taste-texture-health/markets-products/pets/nutrition-health-taste.html
About dsm-firmenich
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for people and the planet. dsm-firmenich is a Swiss company with dual headquarters in Kaiseraugst, Switzerland and Maastricht, Netherlands, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people. www.dsm-firmenich.com
LinkedIn | X | Instagram | Facebook
For more information
BDB (media inquiries)
Oonagh Davies
e-mail: dsmfirmenichTTH@bdb.global
tel. +44 161 521 9465
About Globalfood
Globalfood Advanced Food Technology is a company with nearly 200 years of tradition, with origins in Germany and a well-established presence in Brazil and across South America.
Operating in Brazil since 1987, the company was localized in 1999 and has since operated under the Globalfood brand. It is currently led by Klaus Hasserodt, a fifth-generation member of the founding family, ensuring continuity in governance and the company’s long-standing legacy.
Through a long-standing strategic partnership with dsm-firmenich, Globalfood specializes in the development of ingredient systems for the dairy, cheese, wheat-based products, meat, brewing, ice cream, and vitamins industries, meeting the highest standards of quality, innovation, and industrial performance.
Forward-looking statements
This press release may contain forward-looking statements with respect to dsm-firmenich’s future performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance, transaction progress and positions to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. This communication contains information that qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. The English language version of this press release prevails over other language versions.